Nourish Raises $100M Series C

Nourish, based in New York, is the country's largest dietitian-led metabolic health clinic that leverages AI-native technology to reverse chronic disease. The company announced it has raised $100 million in a Series C funding round, bringing its total funding to $215 million.

Investors

This round was led by Menlo Ventures, a venture capital firm known for investing in disruptive technology companies. Additional participating investors included Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners.

Nourish Use of Funds

The company plans to use the new capital to scale its clinical network, accelerate investment in AI agents for both patients and providers, expand its metabolic clinic care model, and strengthen existing partnerships with health plans, employers, and health systems.

About Nourish

Founded in 2022 by Aidan Dewar, Nourish provides a virtual care model that pairs a network of over 10,000 Registered Dietitians with AI-driven software to deliver personalized, insurance-covered nutrition care and metabolic health support.

Funding Details

Company Website: https://usenourish.com

Company: Nourish
Raised: $100M
Round: Series C
Funding Date: May 12, 2026
Lead Investor: Menlo Ventures
Additional Investors: Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, Operator Partners
Company Website: nourish.com
Software Category: Health Technology
Source: https://www.businesswire.com/news/home/20260512183360/en/Nourish-Raises-%24100M-Series-C-to-Reverse-Chronic-Disease-with-AI-Native-Metabolic-Clinic